Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gilead Science (GILD) Followers -- Ignore unavailable to you. Want to Upgrade?

To: s jones who wrote (521)	5/27/1998 8:29:00 PM
From: John Metcalf	Read Replies (2) \| Respond to of 961

Actually, Biota has a flu diagnostic while Gilead has a treatment for flu. It is possible that the two companies will have a complementary relationship, for example, in institutional care. But -- since flu is short-lived, what is the likelihood that a diagnostic will be done, results evaluated, and then a prescription written? IMO, much more likely that diagnosis will be done from reported symptoms and then a prescription written. In many cases, the patient would not even see the doctor -- just tell doc how you feel over the phone, then pick up a prescription at the pharmacy (drive-up lane, of course).